Epigral Limited (NSE:EPIGRAL)

Epigral Revenue

Epigral had revenue of 7.46B INR in the quarter ending September 30, 2026, with 27.01% growth. This brings the company's total for the last twelve months to 27.85B, up 12.89% year-over-year. In the fiscal year ending March 31, 2026, Epigral had annual revenue of 25.27B, down -0.90%. That makes Epigral the 14,627th largest company in the world by revenue and 749th in India.

• Revenue (ttm): 27.85B
• Revenue Growth: +12.89%
• P/S Ratio: 1.40
• Revenue / Employee: 24.53M
• Employees: 1,135
• Market Cap: 39.00B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 24.18B 96.9%
• outside India 771.80M 3.1%

Fiscal year ended Mar 31, 2026 See the full Epigral breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.27B	-229.50M	-0.90%
Mar 31, 2025	25.50B	6.21B	32.19%
Mar 31, 2024	19.29B	-2.59B	-11.84%
Mar 31, 2023	21.88B	6.37B	41.10%
Mar 31, 2022	15.51B	7.22B	87.18%

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error